All News

2019

July

Media Release / Jul 22, 2019

Sandoz announces first patient enrolled in clinical study for proposed biosimilar denosumab in osteoporosis

Read More
Media Release / Jul 19, 2019

Novartis key multiple sclerosis product Gilenya® approved in China

Read More
Media Release / Jul 18, 2019

Novartis delivers strong sales, double digit core operating income growth and launches Zolgensma and Piqray in second quarter; sales and profit guidance increased

Read More
Novartis Financial Results – Q2 2019
Featured News / Jul 18, 2019

Novartis Financial Results – Q2 2019

Novartis announced the company’s financial results for the second quarter and first half of 2019.

Read More
Media Release / Jul 16, 2019

FDA accepts file and accelerates review of Novartis sickle cell disease medicine crizanlizumab (SEG101)

Read More
Media Release / Jul 11, 2019

Novartis, Amgen and Banner Alzheimer's Institute discontinue clinical program with BACE inhibitor CNP520 for Alzheimer's prevention

Read More
Janneke van der Kamp on the Novartis campus in Basel
Story / Jul 09, 2019

Flexibility at Novartis: Janneke van der Kamp

Van der Kamp explains how leading by example has encouraged others to adopt flexible working models.

Read More
Small pharmacy in Kibera, Nairobi's slum
Featured News / Jul 08, 2019

Global Health & Corporate Responsibility

Novartis transforms its Global Health & Corporate Responsibility organization.

Read More
Media Release / Jul 02, 2019

Sandoz launches oncology generic gefitinib in 13 EU countries at loss of market exclusivity, expanding access to essential medicine

Read More
Media Release / Jul 02, 2019

Novartis highlights cognition data in secondary progressive multiple sclerosis (SPMS)

Read More

Pages

Related Links

Novartis Annual Reporting Suite

Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.

Learn More